2019
DOI: 10.2139/ssrn.3335021
|View full text |Cite
|
Sign up to set email alerts
|

Fibroblast Growth Factor 23 Expression in Human Calcified Vascular Tissues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…FGF23 levels did not differ according to an increase in calcification percentile severity. Although increased expression of FGF23 in human calcified tissue has been shown, 41 Scialla et al 42 described that FGF23 does not have a role in inducing arterial calcification. The opposite was found with sclerostin, a soluble Wnt pathway antagonist and a negative regulator of bone metabolism.…”
Section: Discussionmentioning
confidence: 99%
“…FGF23 levels did not differ according to an increase in calcification percentile severity. Although increased expression of FGF23 in human calcified tissue has been shown, 41 Scialla et al 42 described that FGF23 does not have a role in inducing arterial calcification. The opposite was found with sclerostin, a soluble Wnt pathway antagonist and a negative regulator of bone metabolism.…”
Section: Discussionmentioning
confidence: 99%
“…Some animal studies have shown that RUNX2 expression is required for osteogenic phenotypic change in smooth muscle cells [21]. This transcription factor is also reportedly upregulated in human vascular fragments of large vascular territories where calcification is present [22]. However, evidence of osteogenesis is not a consistent finding across all studies of human VC.…”
Section: Discussionmentioning
confidence: 99%